Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02061618
Other study ID # 13-07-250
Secondary ID
Status Completed
Phase N/A
First received February 10, 2014
Last updated April 1, 2015
Start date June 2014
Est. completion date December 2014

Study information

Verified date April 2015
Source Palo Alto Medical Foundation
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The Culturally Relevant Exercise for Diabetes (CURE-D) study will determine whether a culturally-sensitive dance intervention is an accepted and effective physical intervention for South Asian women with type 2 diabetes mellitus. The CURE-D study will determine if Bollywood dance exercise improves diabetes outcomes in South Asian women.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Sex: Females

- Ethnicity: South Asian

- Hemoglobin A1c = 6.0 mg/dL

- A PAMF patient for = 24 months

- Able and willing to enroll and meet the requirements of the study.

Exclusion Criteria:

- BMI > 35

- Insulin dependent

- Current atrial fibrillation

- Active treatment for cancer

- Diagnosis of a terminal illness and/or in hospice care

- Any serious medical condition which would prevent long-term participation or which would contraindicate physical activity

- Pregnant, lactating, or planning to become pregnant during the study period

- Inability to speak, read, or understand English

- No longer a PAMF patient or planning to transfer care outside of PAMF during the study period

- Investigator discretion for clinical safety or protocol adherence reasons.

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Bollywood Dance Exercise


Locations

Country Name City State
United States Palo Alto Medical Foundation Research Institute Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
Palo Alto Medical Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hemoglobin A1c Baseline No
Primary Hemoglobin A1c Change from Baseline in Hemoglobin A1c level at 8 weeks 8-week follow-up No
Secondary Body Mass Index Baseline, 8-week follow-up No
Secondary Blood Pressure Baseline, 8-week follow-up No
Secondary Physical Activity Assessed by accelerometers Baseline, 8-week follow-up No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A